FDA WARNING_LETTER - Specialty Health Products Inc - December 11, 2025

The FDA issued a warning letter to Specialty Health Products CO, LLC following an inspection of its Phoenix, Arizona facility from December 1 to December 11, 2025. The investigation focused on the company"s colonic irrigation systems and speculum kits, identifying significant violations of the Federal Food, Drug, and Cosmetic Act and the Quality System Regulation. Main violations included a failure to perform necessary design validation for product biocompatibility and shelf life, making unauthorized hardware changes without documentation, and maintaining inadequate manufacturing and disinfection controls. The firm also failed to properly investigate customer complaints and lacked secure document management systems. Furthermore, the FDA determined the company was marketing its devices for unapproved "wellness" and "detoxification" purposes, which differs significantly from the medically indicated uses cleared by the agency. This shift in intended use, combined with technological modifications like new UV light units, requires new regulatory submissions that the company failed to provide. Additionally, the firm failed to register its products in the global tracking database (GUDID) and incorrectly filed its establishment registration. Specialty Health Products must immediately cease the distribution of these unapproved devices. The company is required to provide a written response within fifteen business days outlining a comprehensive plan to correct these systemic quality management failures and ensure future compliance with federal regulations. Failure to address these issues may result in product seizures, injunctions, or financial penalties.